FIRST MERCANTILE TRUST CO - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 275 filers reported holding MYRIAD GENETICS INC in Q4 2013. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST MERCANTILE TRUST CO ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q4 2019$330,000
-10.8%
12,132
-6.1%
0.04%
-2.6%
Q3 2019$370,000
-0.3%
12,922
-3.3%
0.04%0.0%
Q2 2019$371,000
+9.1%
13,362
+30.3%
0.04%
-51.2%
Q1 2019$340,000
+9.3%
10,253
-4.1%
0.08%
+6.7%
Q4 2018$311,000
-41.0%
10,692
-6.7%
0.08%
-27.9%
Q3 2018$527,000
+17.4%
11,456
-4.6%
0.10%
+15.6%
Q2 2018$449,000
+21.0%
12,008
-4.4%
0.09%
+15.4%
Q1 2018$371,000
+66.4%
12,561
+93.2%
0.08%
+77.3%
Q4 2017$223,000
-18.6%
6,501
-14.1%
0.04%
-12.0%
Q3 2017$274,000
+37.7%
7,568
-1.6%
0.05%
+38.9%
Q2 2017$199,000
+4.2%
7,693
-22.5%
0.04%
+24.1%
Q1 2017$191,000
+4.9%
9,928
-9.3%
0.03%
+3.6%
Q4 2016$182,000
-50.5%
10,940
-38.8%
0.03%
-42.9%
Q3 2016$368,000
-21.4%
17,887
+17.0%
0.05%
-15.5%
Q2 2016$468,000
-18.8%
15,294
-0.6%
0.06%
-17.1%
Q1 2016$576,000
-21.1%
15,388
-9.1%
0.07%
-6.7%
Q4 2015$730,000
-5.4%
16,923
-17.9%
0.08%
-3.8%
Q3 2015$772,000
+12.9%
20,625
+2.4%
0.08%
+32.2%
Q2 2015$684,000
-24.0%
20,149
-20.8%
0.06%
-21.3%
Q1 2015$900,000
+26.8%
25,434
+22.0%
0.08%
+27.1%
Q4 2014$710,000
-14.8%
20,840
-3.5%
0.06%
-11.9%
Q3 2014$833,000
-18.7%
21,596
-18.0%
0.07%
-18.3%
Q2 2014$1,025,000
+35.9%
26,330
+19.4%
0.08%
+49.1%
Q1 2014$754,000
+43.1%
22,060
-12.1%
0.06%
+34.1%
Q4 2013$527,000
-16.5%
25,105
-6.6%
0.04%
-19.6%
Q3 2013$631,000
-39.1%
26,870
-30.3%
0.05%
-42.7%
Q2 2013$1,036,00038,5450.09%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Camber Capital Management LP 5,500,000$134,5303.72%
Glenview Capital Management 3,748,432$91,686,6471.80%
ORACLE INVESTMENT MANAGEMENT INC 60,000$1,467,6001.37%
ESSEX INVESTMENT MANAGEMENT CO LLC 240,128$5,873,5311.10%
DISCIPLINED GROWTH INVESTORS INC /MN 2,087,328$51,056,0430.96%
OBERWEIS ASSET MANAGEMENT INC/ 360,700$8,822,7220.54%
EARNEST PARTNERS LLC 4,072,018$99,601,5600.47%
AIMZ Investment Advisors, LLC 39,585$968,2490.35%
Eversept Partners, LP 181,961$4,450,7660.30%
Hillsdale Investment Management Inc. 151,180$3,697,8630.29%
View complete list of MYRIAD GENETICS INC shareholders